Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab
- DOI
- 10.1093/rheumatology/keaf254
- Published
- 2025-06-15
- Container
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/rheumatology/keaf254,
title = {Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab},
author = {Koji Suzuki and Hideto Kameda and Kei Ikeda and Tomonori Ishii and Kosaku Murakami and Hyota Takamatsu and Yoshiya Tanaka and Takayuki Abe and Tsutomu Takeuchi and Yuko Kaneko},
year = {2025},
journal = {Rheumatology},
doi = {10.1093/rheumatology/keaf254},
url = {https://doi.org/10.1093/rheumatology/keaf254}
}RIS
TY - JOUR TI - Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab AU - Koji Suzuki AU - Hideto Kameda AU - Kei Ikeda AU - Tomonori Ishii AU - Kosaku Murakami AU - Hyota Takamatsu AU - Yoshiya Tanaka AU - Takayuki Abe AU - Tsutomu Takeuchi AU - Yuko Kaneko PY - 2025 JO - Rheumatology DO - 10.1093/rheumatology/keaf254 UR - https://doi.org/10.1093/rheumatology/keaf254 ER -
APA
Suzuki, K., Kameda, H., Ikeda, K., Ishii, T., Murakami, K., Takamatsu, H., Tanaka, Y., Abe, T., Takeuchi, T., & Kaneko, Y. (2025). Serum cytokine levels towards precision medicine in Still’s disease: a subanalysis of a randomized controlled trial of tocilizumab. Rheumatology. https://doi.org/10.1093/rheumatology/keaf254
Source records
- crossref · retrieved 2026-09-27T05:05:09.640Z